Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

Luz M. Canet; Jose M. Sánchez-Maldonado; Rafael Cáliz; Ana Rodríguez-Ramos; Carmen B. Lupiañez; Helena Canhão; Manuel Martínez-Bueno; Alejandro Escudero; Juana Segura-Catena; Signe B. Sorensen; Merete L. Hetland; María José Soto-Pino; Miguel A. Ferrer; Antonio García; Bente Glintborg; Ileana Filipescu; Eva Pérez-Pampin; Alfonso González-Utrilla; Miguel Ángel López Nevot; Pablo Conesa-Zamora; Alfons den Broeder; Salvatore De Vita; Sven Erik Hobe Jacobsen; Eduardo Collantes-Estevez; Luca Quartuccio; Federico Canzian; João E. Fonseca; Marieke J.H. Coenen; Vibeke Andersen; Juan Sainz

doi:10.1038/s41397-019-0084-2

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

Luz M. Canet, Jose M. Sánchez-Maldonado, Rafael Cáliz, Ana Rodríguez-Ramos, Carmen B. Lupiañez, Helena Canhão, Manuel Martínez-Bueno, Alejandro Escudero, Juana Segura-Catena, Signe B. Sorensen, Merete L. Hetland, María José Soto-Pino, Miguel A. Ferrer, Antonio García, Bente Glintborg, Ileana Filipescu, Eva Pérez-Pampin, Alfonso González-Utrilla, Miguel Ángel López Nevot, Pablo Conesa-ZamoraAlfons den Broeder, Salvatore De Vita, Sven Erik Hobe Jacobsen, Eduardo Collantes-Estevez, Luca Quartuccio, Federico Canzian, João E. Fonseca, Marieke J.H. Coenen, Vibeke Andersen, Juan Sainz^*

^*Kontaktforfatter

IRS - Sygehus Sønderjylland

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Abstract

The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.

Originalsprog	Engelsk
Tidsskrift	Pharmacogenomics Journal
Vol/bind	19
Sider (fra-til)	582
Antal sider	1
ISSN	1470-269X
DOI	https://doi.org/10.1038/s41397-019-0084-2
Status	Udgivet - 1. jan. 2019

Dokumenter og links

10.1038/s41397-019-0084-2

Fingeraftryk

Dyk ned i forskningsemnerne om 'Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Canet, L. M., Sánchez-Maldonado, J. M., Cáliz, R., Rodríguez-Ramos, A., Lupiañez, C. B., Canhão, H., Martínez-Bueno, M., Escudero, A., Segura-Catena, J., Sorensen, S. B., Hetland, M. L., Soto-Pino, M. J., Ferrer, M. A., García, A., Glintborg, B., Filipescu, I., Pérez-Pampin, E., González-Utrilla, A., Nevot, M. Á. L., ... Sainz, J. (2019). Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x). Pharmacogenomics Journal, 19, 582. https://doi.org/10.1038/s41397-019-0084-2

@article{5aaf43454c2f45f693393f17867e9196,

title = "Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)",

abstract = "The original version of this Article contained an error in the spelling of the author Ana Rodr{\'i}guez-Ramos, which was incorrectly given as Ana Rodr{\'i}guez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.",

author = "Canet, {Luz M.} and S{\'a}nchez-Maldonado, {Jose M.} and Rafael C{\'a}liz and Ana Rodr{\'i}guez-Ramos and Lupia{\~n}ez, {Carmen B.} and Helena Canh{\~a}o and Manuel Mart{\'i}nez-Bueno and Alejandro Escudero and Juana Segura-Catena and Sorensen, {Signe B.} and Hetland, {Merete L.} and Soto-Pino, {Mar{\'i}a Jos{\'e}} and Ferrer, {Miguel A.} and Antonio Garc{\'i}a and Bente Glintborg and Ileana Filipescu and Eva P{\'e}rez-Pampin and Alfonso Gonz{\'a}lez-Utrilla and Nevot, {Miguel {\'A}ngel L{\'o}pez} and Pablo Conesa-Zamora and {den Broeder}, Alfons and {De Vita}, Salvatore and Jacobsen, {Sven Erik Hobe} and Eduardo Collantes-Estevez and Luca Quartuccio and Federico Canzian and Fonseca, {Jo{\~a}o E.} and Coenen, {Marieke J.H.} and Vibeke Andersen and Juan Sainz",

year = "2019",

month = jan,

day = "1",

doi = "10.1038/s41397-019-0084-2",

language = "English",

volume = "19",

pages = "582",

journal = "Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer",

}

Canet, LM, Sánchez-Maldonado, JM, Cáliz, R, Rodríguez-Ramos, A, Lupiañez, CB, Canhão, H, Martínez-Bueno, M, Escudero, A, Segura-Catena, J, Sorensen, SB, Hetland, ML, Soto-Pino, MJ, Ferrer, MA, García, A, Glintborg, B, Filipescu, I, Pérez-Pampin, E, González-Utrilla, A, Nevot, MÁL, Conesa-Zamora, P, den Broeder, A, De Vita, S, Jacobsen, SEH, Collantes-Estevez, E, Quartuccio, L, Canzian, F, Fonseca, JE, Coenen, MJH, Andersen, V & Sainz, J 2019, 'Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)', Pharmacogenomics Journal, bind 19, s. 582. https://doi.org/10.1038/s41397-019-0084-2

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x). / Canet, Luz M.; Sánchez-Maldonado, Jose M.; Cáliz, Rafael et al.
I: Pharmacogenomics Journal, Bind 19, 01.01.2019, s. 582.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

TY - JOUR

T1 - Correction

T2 - Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

AU - Canet, Luz M.

AU - Sánchez-Maldonado, Jose M.

AU - Cáliz, Rafael

AU - Rodríguez-Ramos, Ana

AU - Lupiañez, Carmen B.

AU - Canhão, Helena

AU - Martínez-Bueno, Manuel

AU - Escudero, Alejandro

AU - Segura-Catena, Juana

AU - Sorensen, Signe B.

AU - Hetland, Merete L.

AU - Soto-Pino, María José

AU - Ferrer, Miguel A.

AU - García, Antonio

AU - Glintborg, Bente

AU - Filipescu, Ileana

AU - Pérez-Pampin, Eva

AU - González-Utrilla, Alfonso

AU - Nevot, Miguel Ángel López

AU - Conesa-Zamora, Pablo

AU - den Broeder, Alfons

AU - De Vita, Salvatore

AU - Jacobsen, Sven Erik Hobe

AU - Collantes-Estevez, Eduardo

AU - Quartuccio, Luca

AU - Canzian, Federico

AU - Fonseca, João E.

AU - Coenen, Marieke J.H.

AU - Andersen, Vibeke

AU - Sainz, Juan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.

AB - The original version of this Article contained an error in the spelling of the author Ana Rodríguez-Ramos, which was incorrectly given as Ana Rodríguez Ramos. This has now been corrected in both the PDF and HTML versions of the Article.

U2 - 10.1038/s41397-019-0084-2

DO - 10.1038/s41397-019-0084-2

M3 - Comment/debate

C2 - 30760878

AN - SCOPUS:85061477711

SN - 1470-269X

VL - 19

SP - 582

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

ER -

Canet LM, Sánchez-Maldonado JM, Cáliz R, Rodríguez-Ramos A, Lupiañez CB, Canhão H et al. Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x). Pharmacogenomics Journal. 2019 jan. 1;19:582. doi: 10.1038/s41397-019-0084-2